Fritextsökning
Artiklar per år
Innehållstyper
-
Två nya krafter till LUAB
Lunds universitets utvecklingsbolag rekryterar två nyckelpersoner som bland annat ska ansvara för riskkapital och affärsutveckling.
-
Proteiner värda att mjölka
En av Sveriges största mjölkproducenter har skrivit avtal om att tillverka vassleproteiner på plats i USA. Produktionen börjar i sommar.
-
Mycket på gång i Moberg Derma
Bolaget har tecknat avtal kring en teknologiplattform för att spreja på läkemedel. Ett licensavtal med ett av Sveriges största hudvårdsbolag ska leda till en ny behandling mot nagelsvamp, och i höst lanseras en helt ny produktserie.
-
EU vill upphäva GMO-förbud
Österrike kan tvingas tillåta odling av genmodifierad majs. Detta trots att landet införde förbud mot grödan för tio år sedan.
-
Ledarförändringar i Danisco
Produktchef i divisionen för livsmedelsenzym tar ett steg upp.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
BREAKING